Song B
Int J Mol Sci. 2025; 26(5).
PMID: 40076976
PMC: 11900391.
DOI: 10.3390/ijms26052357.
Muller A, Sullivan J, Schwarzer W, Wang M, Park-Windhol C, Hasler P
Nat Med. 2025; 31(2):490-501.
PMID: 39779923
PMC: 11835749.
DOI: 10.1038/s41591-024-03422-8.
Alves C, Das S, Krishnan V, Ha L, Fox L, Stutzman H
bioRxiv. 2024; .
PMID: 39605323
PMC: 11601241.
DOI: 10.1101/2024.11.11.621817.
Hwang G, Lee S, Oh M, Kim S, Habib O, Jang H
Nat Biomed Eng. 2024; 9(1):79-92.
PMID: 39496933
PMC: 11754094.
DOI: 10.1038/s41551-024-01277-5.
Bzhilyanskaya V, Ma L, Liu S, Fox L, Whittaker M, Meis R
Sci Transl Med. 2024; 16(769):eadj6779.
PMID: 39413163
PMC: 11753194.
DOI: 10.1126/scitranslmed.adj6779.
Engineering TadA ortholog-derived cytosine base editor without motif preference and adenosine activity limitation.
Li G, Dong X, Luo J, Yuan T, Li T, Zhao G
Nat Commun. 2024; 15(1):8090.
PMID: 39284833
PMC: 11405849.
DOI: 10.1038/s41467-024-52485-1.
Unveiling the Genomic Symphony: Identification Cultivar-Specific Genes and Enhanced Insights on Sweet Sorghum Genomes Through Comprehensive superTranscriptomic Analysis.
Nikhil S, Mohideen H, Natesan Sella R
J Mol Evol. 2024; 92(6):720-743.
PMID: 39261311
DOI: 10.1007/s00239-024-10198-5.
Discovery of novel disease-causing mutation in and its correction using adenine base editor to improve mitochondrial function.
Cha J, Lee S, Yun Y, Choi W, Koo H, Jung S
Mol Ther Nucleic Acids. 2024; 35(3):102257.
PMID: 39104869
PMC: 11299580.
DOI: 10.1016/j.omtn.2024.102257.
Gene therapy for inherited retinal diseases: exploiting new tools in genome editing and nanotechnology.
Carvalho C, Lemos L, Antas P, Seabra M
Front Ophthalmol (Lausanne). 2024; 3:1270561.
PMID: 38983081
PMC: 11182192.
DOI: 10.3389/fopht.2023.1270561.
Library-Assisted Evolution in Eukaryotic Cells Yield Adenine Base Editors with Enhanced Editing Specificity.
Hsiao S, Chen S, Jiang Y, Wang Q, Yang Y, Lai Y
Adv Sci (Weinh). 2024; 11(30):e2309004.
PMID: 38874509
PMC: 11321652.
DOI: 10.1002/advs.202309004.
Evolution of Prime Editing Systems: Move Forward to the Treatment of Hereditary Diseases.
Volodina O, Fabrichnikova A, Anuchina A, Mishina O, Lavrov A, Smirnikhina S
Curr Gene Ther. 2024; 25(1):46-61.
PMID: 38623982
DOI: 10.2174/0115665232295117240405070809.
Breaking genetic shackles: The advance of base editing in genetic disorder treatment.
Xu F, Zheng C, Xu W, Zhang S, Liu S, Chen X
Front Pharmacol. 2024; 15:1364135.
PMID: 38510648
PMC: 10953296.
DOI: 10.3389/fphar.2024.1364135.
Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?.
Lonez C, Breman E
Cells. 2024; 13(2).
PMID: 38247837
PMC: 10814647.
DOI: 10.3390/cells13020146.
Split complementation of base editors to minimize off-target edits.
Xiong X, Liu K, Li Z, Xia F, Ruan X, He X
Nat Plants. 2023; 9(11):1832-1847.
PMID: 37845337
DOI: 10.1038/s41477-023-01540-8.
Site-specific genome editing in treatment of inherited diseases: possibility, progress, and perspectives.
Huang C, Li Q, Li J
Med Rev (2021). 2023; 2(5):471-500.
PMID: 37724161
PMC: 10388762.
DOI: 10.1515/mr-2022-0029.
Precise genome editing with base editors.
Liu H, Zhu Y, Li M, Gu Z
Med Rev (2021). 2023; 3(1):75-84.
PMID: 37724105
PMC: 10471085.
DOI: 10.1515/mr-2022-0044.
Directed evolution rice genes with randomly multiplexed sgRNAs assembly of base editors.
Zhang A, Shan T, Sun Y, Chen Z, Hu J, Hu Z
Plant Biotechnol J. 2023; 21(12):2597-2610.
PMID: 37571976
PMC: 10651138.
DOI: 10.1111/pbi.14156.
Unlocking the secrets of ABEs: the molecular mechanism behind their specificity.
Chen X, McAndrew M, Lapinaite A
Biochem Soc Trans. 2023; 51(4):1635-1646.
PMID: 37526140
PMC: 10586758.
DOI: 10.1042/BST20221508.
Amphioxus adenosine-to-inosine tRNA-editing enzyme that can perform C-to-U and A-to-I deamination of DNA.
Gao Z, Jiang W, Zhang Y, Zhang L, Yi M, Wang H
Commun Biol. 2023; 6(1):744.
PMID: 37464027
PMC: 10354150.
DOI: 10.1038/s42003-023-05134-0.
Base editors: development and applications in biomedicine.
Liang Y, Chen F, Wang K, Lai L
Front Med. 2023; 17(3):359-387.
PMID: 37434066
DOI: 10.1007/s11684-023-1013-y.